American Financial Group’s Cognition Therapeutics CGTX Stock Holding History

American Financial Group’s Portfolio CGTX Stock Details CGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$236K	Hold	205,000	–	–	0.08%	67
2026 Q1	$156K	Hold	205,000	–	–	0.06%	66
2025 Q4	$277K	Hold	205,000	–	–	0.1%	57
2025 Q3	$277K	Hold	205,000	–	–	0.11%	50
2025 Q2	$63.5K	Hold	205,000	–	–	0.02%	61
2025 Q1	$86.3K	Hold	205,000	–	–	0.04%	59
2024 Q4	$144K	Hold	205,000	–	–	0.07%	59
2024 Q3	$96K	Hold	205,000	–	–	0.04%	64
2024 Q2	$340K	Hold	205,000	–	–	0.15%	56
2024 Q1	$373K	Hold	205,000	–	–	0.14%	59
2023 Q4	$379K	Hold	205,000	–	–	0.14%	64
2023 Q3	$295K	Hold	205,000	–	–	0.1%	72
2023 Q2	$375K	Hold	205,000	–	–	0.12%	73
2023 Q1	$406K	Hold	205,000	–	–	0.13%	73
2022 Q4	$430K	Hold	205,000	–	–	0.14%	75
2022 Q3	$389K	Hold	205,000	–	–	0.13%	75
2022 Q2	$432K	Hold	205,000	–	–	0.15%	73
2022 Q1	$564K	Hold	205,000	–	–	0.17%	68
2021 Q4	$1.3M	Buy	+205,000	New	+$2M	0.35%	52

Other funds holding CGTX

BCM

BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.17B AUM 42.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

HCM

Hilton Capital Management Garden City, New York $1.47B AUM 18.73% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

American Financial Group's CGTX Position: Q2 2026 in Review

American Financial Group held its Cognition Therapeutics (CGTX) position steady in Q2 2026 at 205,000 shares worth $236K. The position accounts for 0.08% of the portfolio, ranked #67.

American Financial Group first reported a position in CGTX in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.3M in Q4 2021. 66 funds tracked by Wall St. Rank hold CGTX as of Q2 2026.

American Financial Group held 205,000 shares of Cognition Therapeutics worth $236K as of Q2 2026.
American Financial Group left its Cognition Therapeutics share count unchanged in Q2 2026.
Cognition Therapeutics made up 0.08% of American Financial Group's portfolio in Q2 2026, its #67 holding.
American Financial Group first reported a position in Cognition Therapeutics in Q4 2021 and has held it in 19 quarters since.
American Financial Group's Cognition Therapeutics position peaked at $1.3M in Q4 2021.
66 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q2 2026.

Based on American Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.